Author

Donna R. R Rivera

2020 · Nicole M Kuderer, Toni K Choueiri, et al. · The Lancet · 1,726
2017 · Donna R. Rivera, Lisa Gallicchio, et al. · JAMA Oncology · 235
2019 · Lindsey Enewold, Helen Parsons, et al. · JNCI Monographs · 159
2022 · P.S. Mishra-Kalyani, L. Amiri Kordestani, et al. · Annals of Oncology · 139
2017 · Hanna Bandos, Joy Melnikow, et al. · JNCI Journal of the National Cancer Institute · 129
2021 · Lynne T. Penberthy, Donna R. Rivera, et al. · CA A Cancer Journal for Clinicians · 98
2021 · Rimma Belenkaya, Michael J. Gurley, et al. · JCO Clinical Cancer Informatics · 94
2017 · Donna R. Rivera, Patricia A. Ganz, et al. · JNCI Journal of the National Cancer Institute · 94
2016 · Jeremy Brown, Corita Grudzen, et al. · Annals of Emergency Medicine · 66
2021 · Donna R. Rivera, Henry J. Henk, et al. · Clinical Pharmacology & Therapeutics · 60
2023 · Sonia Singh, Diana Bradford, et al. · Clinical Cancer Research · 51
2020 · S.M.Shamimul Hasan, Donna Rivera, et al. · IEEE Journal of Biomedical and Health Informatics · 50
2020 · Monica E. D’Arcy, Ruth M. Pfeiffer, et al. · JAMA Dermatology · 41
2019 · Ruth M. Pfeiffer, Bernd Mayer, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 41
2021 · Monica E. D'Arcy, Daniel C. Beachler, et al. · Cancer Epidemiology Biomarkers & Prevention · 38
2021 · Arielle Elkrief, Julie T. Wu, et al. · Cancer Discovery · 37
2020 · Donna R. Rivera, Mugdha N. Gokhale, et al. · Pharmacoepidemiology and Drug Safety · 36
2025 · Karin de Haart, Keiko Asao, et al. · Drug Discovery Today · 32
2025 · Ali B. Abbasi, Jennifer Layden, et al. · JAMA · 31
2020 · Colleen S. Curran, Donna R. Rivera, et al. · Frontiers in Pharmacology · 30
Works count: 191
Citation count: 4,675
H-index: 27
I10-index: 59
Year
Topic
Type